top of page
BIO
Joe Soto
CEO
Joe Soto serves as Epica International’s CEO and shares in consulting and directorial duties. He is a co-founder and chief executive officer of Facilitated Growth LLC, a management consulting firm based in New York City, that specializes in capital strategy and business development for early-stage companies. Mr. Soto handles the Firm’s financial structuring, investment opportunities, and limited partner relations. Prior to Facilitated Growth, Mr. Soto served as the chief financial officer of Jurasic Industries and as a commercial banking specialist for Quadrant Funding, LLC. Across Mr. Soto’s private equity interests, he holds various advisory and directorial positions, primarily on behalf of Facilitated Growth. Mr. Soto attended Mercyhurst College, where he earned a Bachelor of Science degree in business administration and a BA in hospitality management.
BIO
Stefano Severini
Presdient of Italian Operations
.png)
Dr. Severini holds a Master's degree in Economics and Business Management from the University of Pisa and a postgraduate diploma for Executives in Company Management. He is also a Chartered Accountant. Dr. Severini has spent a highly successful career in the development and growth of his own investment company. He is also engaged as a business and corporate development advisor.
In 2011, Dr Severini assumed the role of advisor to Gruppo Scienzia Machinale s.r.l., a co-founding company of Epica International, Inc. and one of its primary shareholders. Over time, he held the position of external CFO for the Robotics and R&D divisions of Roboticom and a member of the executive committee. Dr. Severini then became a shareholder of Gruppo Scienzia Machinale s.r.l. assuming the role of CEO in 2020. He continues to serve Epica International, Inc. as an external advisor.
BIO
Ben Hill
Presdient of US Operations
Ben Hill, President of Epica International and board member at Imaginalis, is a dynamic leader in sales and operations, specializing in propelling disruptive technologies across diverse markets. His strategic prowess in sales and marketing has consistently delivered robust revenue increases.
Adept at leading sizable teams, Ben's expertise was pivotal at Medtronic as the National Director of Surgical Synergy, where he spearheaded sales and clinical groups to enhance surgical technologies, contributing to substantial revenue growth and the successful integration of Mazor Robotics. His tenure at Mazor was marked by versatile leadership roles and was instrumental in Medtronic's $1.6 billion acquisition of the company.
Ben's academic background includes a BS in Communications from Wingate University, where he also distinguished himself as an All-American soccer player.
BIO
Craig Glaiberman, M.D.
Chief Medical Officer
Dr. Glaiberman is a board-certified interventional radiologist. He completed residency at Penn State and a fellowship at Washington University in St. Louis, Missouri where he was invited to stay on as faculty. While in St. Louis, he specialized in liver-directed therapies for portal hypertension and cancer. He performed research in medical simulation and has many publications in peer reviewed journals.
In 2008, he returned to California to join UC Davis radiology faculty. Turning to private practice, he then joined the Sutter Health System as an interventional radiologist until retiring in 2020. He has collaborated with the UC Davis School of Veterinary Medicine since 2010. He continues to participate in cases, teaching, and publications as Volunteer Clinical Faculty.
Through veterinary connections, Dr. Glaiberman became introduced to Epica International in 2015. After serving for 5 years on the company’s medical advisory board, he was invited to become its Clinical Director. He was appointed Chief Medical Officer in 2023.
BIO
Greg Stoutenburgh
Founder of Epica Medical Innovations, Director
Greg Stoutenburgh is the founder of Epica Medical Innovations and Epica International. He currently serves Epica as Sr. VP of Peregrine Radiology and also in Product Development, Applications, Training, and Marketing. Prior to founding the Epica companies in 2012, Mr. Stoutenburgh spent 22 years operating over 100 Veterinary practices in various capacities as well as some medical and dental practices. He founded and managed CORE Veterinary Management, Symphony Veterinary Management, and California Veterinary Practices, LLC. In 2005 while still operating his own practices Mr. Stoutenburgh began working for Sound-Eklin, a division of VCA Antech as VP of Marketing and Advanced Modalities where he was responsible for capital equipment and software development for the largest Imaging company in veterinary medicine. With Sound he developed and brought successfully to market several Digital Radiography systems, PACS Software Solutions, 2 Surgical planning software applications, 3D Software for CT and MR, an Electronic Brachytherapy platform for intraoperative radiation therapy, and High Intensity Laser Therapy. In this capacity working with Lasers Mr. Stoutenburgh met Damiano Fortuna and they conceived of a plan to create the prototype of Vimago with a group of Italian engineering firms and then formed Epica. Mr. Stoutenburgh Received his BS in Biology: Ecology and Environmental Biology and did his graduate studies in Evolutionary Ecology and Complexity.
BIO
Thomas Grossman
Chairman, Board of Directors
Mr. Grossman presently runs Union Avenue Advisors LP, a company he founded in 2009, where he builds customized portfolios for separately managed accounts in the international markets. Prior to starting Union Avenue Advisors, Mr. Grossman was a portfolio manager at Ospraie Management, LLC from 2007 to 2008. He also established Aeneas Capital Management in 2000 and ran the business through 2008. Mr. Grossman’s extensive financial background includes positions as director of SAC International Equities LLC from 1997-2000, head of international trading for Kingdom Capital Management LLC from 1994-1997, international sales and trading desk at Goldman Sachs & Co from 1992-1994, an analyst at Bridge Trading Co. from 1990-1992, and trader in equity options at Shearson Lehman Hutton from 1988-1990. Mr. Grossman graduated cum laude from Lehigh University, where he received a BS in finance.
BIO
Randy Axelrod, M.D.
Director
Dr. Axelrod is a Seasoned Physician executive and healthcare thought leader with more than 30 years of cumulative experience, accountability, and achievements in for-profit, public, and not-for-profit healthcare organizations with responsibility in all areas of healthcare and financial structures, initiating, managing, and operating multibillion-dollar businesses and developing and executing comprehensive strategic plans resulting in improved financial returns, clinician engagement, clinical improvements, and healthier communities.Dr. Axelrod served as the Executive Vice President and Chief Clinical Officer for Providence Health & Services, organizing system-wide quality and safety, clinical programs, clinical innovation, research evaluation, and key supply chain and capital purchase strategies. Previously he served as SVP for Healthcare Management at WellPoint, the VP and Executive Medical Director at Sentara Healthcare, and the President of HealthSpring Medical Group. Dr. Axelrod’s work on the use of artificial intelligence in health care resulted in internationally accepted publications and several national awards. Recently Dr. Axelrod and the POWERDOT team won first place in the Heritage Health Plan predictive modeling contest at the first and second milestones and final competition – a contest predicting readmissions. He has also received the Virginia Public Health Association Recognition Award.Dr. Axelrod earned his MD at The University of Cincinnati Medical School and was a practicing pediatric physician and surgeon.
BIO
Bruce Holstien
Director
With over three decades in healthcare, Bruce's unique experience spans non-profit, governmental, and for-profit sectors. Since 1993, he's played a pivotal role in the growth of integrated health systems, including insurance operations. As CEO of Apella Health for 14 years, Bruce oversees the $2.2 billion Spartanburg Health System, impacting over 1.8 million people. His leadership has garnered significant improvements in safety, quality, and innovation while ensuring financial stability. A notable speaker on cancer care disparities and a pioneer in multi-disciplinary cancer centers, Bruce co-founded the Guardian Research Network to fuse molecular biology with big data for faster disease cures. His "Beyond the Human Genome" project aims to revolutionize medical research through comprehensive digital profiles. Recognized with numerous awards for his humanitarian and economic contributions, Bruce is a respected board member of various health and arts organizations. He holds degrees in Healthcare Administration, Clinical Gerontology, and Business Administration.
BIO
John (Jack) Tomayko
Director
John (Jack) R. Tomayko received his undergraduate degree in Business Administration from Villanova University and his Ph.D. in Health Administration from the University of Pittsburgh. Jack has been a CEO for over 35 years operating healthcare companies; MAIN Medical, Inc., The Tomayko Group (TTG), and TTG Imaging Solutions. During his tenure, the companies received 18 awards representing Fastest Growth, Best Places to Work and Healthiest Employer. In 2012, he was awarded the Ernst & Young Regional Entrepreneur of the Year in the Healthcare Division.
Jack is currently the owner and President of Tomayko Group Holdings, Inc., an investment and consulting company specializing in healthcare with a concentration in preventative health services. He is also a Board Member of TTG Imaging Solutions and serves on numerous non-profit Boards including, Point Park University, College of Fine Arts/Carnegie Mellon University and School of Education/University of Pittsburgh.
BIO
Team Bio: Thomas Grossman
Thomas Grossman
Chairman, Board of Directors
BIO
Randy Axelrod
CEO of Epica International, Director
Team Bios: Randy Axelrod
Dr. Axelrod is a Seasoned Physician executive and healthcare thought leader with more than 30 years of cumulative experience, accountability, and achievements in for-profit, public, and not-for-profit healthcare organizations with responsibility in all areas of healthcare and financial structures, initiating, managing, and operating multibillion-dollar businesses and developing and executing comprehensive strategic plans resulting in improved financial returns, clinician engagement, clinical improvements, and healthier communities.
Dr. Axelrod served as the Executive Vice President and Chief Clinical Officer for Providence Health & Services, organizing system-wide quality and safety, clinical programs, clinical innovation, research evaluation, and key supply chain and capital purchase strategies. Previously he served as SVP for Healthcare Management at WellPoint, the VP and Executive Medical Director at Sentara Healthcare, and the President of HealthSpring Medical Group. Dr. Axelrod’s work on the use of artificial intelligence in health care resulted in internationally accepted publications and several national awards. Recently Dr. Axelrod and the POWERDOT team won first place in the Heritage Health Plan predictive modeling contest at the first and second milestones and final competition – a contest predicting readmissions. He has also received the Virginia Public Health Association Recognition Award.
Dr. Axelrod earned his MD at The University of Cincinnati Medical School and was a practicing pediatric physician and surgeon.
bottom of page